Michael A. DesJardin - Jan 4, 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
EVP, Technical Operations
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Jan 4, 2022
Transactions value $
-$4,203,548
Form type
4
Date filed
1/6/2022, 07:59 PM
Previous filing
Jul 30, 2021
Next filing
Jan 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +53.7K +59.08% 145K Jan 5, 2022 Direct F1, F2
transaction HZNP Ordinary Shares Award $0 +32.3K +22.33% $0.00 177K Jan 5, 2022 Direct F3
transaction HZNP Ordinary Shares Tax liability -$4.2M -41.3K -23.32% $101.84 136K Jan 5, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units (RSU) Award $0 +21.4K $0.00 21.4K Jan 4, 2022 Ordinary Shares 21.4K Direct F1, F4
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -12.3K -100% $0.00* 0 Jan 5, 2022 Ordinary Shares 12.3K Direct F1, F5
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -12.1K -50% $0.00 12.1K Jan 5, 2022 Ordinary Shares 12.1K Direct F1, F6
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -10.5K -33.33% $0.00 21K Jan 5, 2022 Ordinary Shares 10.5K Direct F1, F7
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -9.22K -50% $0.00 9.22K Jan 5, 2022 Ordinary Shares 9.22K Direct F1, F8
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -9.68K -66.69% $0.00 4.83K Jan 5, 2022 Ordinary Shares 9.68K Direct F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one ordinary share of the Issuer.
F2 Includes 2 ordinary shares of the Issuer acquired by the reporting person on December 1, 2021 pursuant to an employee stock purchase program.
F3 On January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 5, 2022, the PSUs vested as to the number of shares reported above.
F4 The RSU's vest 1/3rd annually on each anniversary of January 5, 2022.
F5 The RSU's vest 1/3rd annually on each anniversary of January 5, 2019.
F6 The RSU's vest 1/3rd annually on each anniversary of January 5, 2020.
F7 The RSU's vest 1/3rd annually on each anniversary of January 5, 2021.
F8 50% of the shares subject to the RSUs vested on January 5, 2022, and the remaining shares vest on 1/5/2023.
F9 Two-thirds of the ordinary shares subject to the RSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023.